Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Vascular Surgery

Free Subscription Articles published in Lancet Retrieve available abstracts of 37 articles: HTML format

Single Articles

July 2022
1. KHATRI P
   Intravenous thrombolysis before thrombectomy for acute ischaemic stroke.
   Lancet. 2022;400:76-78.
   PubMed    
   
   
   
2. MITCHELL PJ, Yan B, Churilov L, Dowling RJ, et al
   Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4.5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial.
   Lancet. 2022;400:116-125.
   PubMed     Abstract available
   
   
   
3. FISCHER U, Kaesmacher J, Strbian D, Eker O, et al
   Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial.
   Lancet. 2022;400:104-115.
   PubMed     Abstract available
   
   
   March 2022
4. HALLIDAY A, Bulbulia R, Bonati LH, Chester J, et al
   Is stenting equivalent to endarterectomy for asymptomatic carotid stenosis? - Authors' reply.
   Lancet. 2022;399:1116.
   PubMed    
   
   
   
5. ABBOTT AL, Wijeratne T, Zeebregts CJ, Ricco JB, et al
   Is stenting equivalent to endarterectomy for asymptomatic carotid stenosis?
   Lancet. 2022;399:1115-1116.
   PubMed    
   
   
   
6. KAMTCHUM-TATUENE J, Jickling GC
   Is stenting equivalent to endarterectomy for asymptomatic carotid stenosis?
   Lancet. 2022;399:1114-1115.
   PubMed    
   
   
   February 2022
7. ALMEKHLAFI MA, Coutts SB
   Anti-thrombotics cause harm in the setting of stroke thrombectomy.
   Lancet. 2022 Feb 28. pii: S0140-6736(22)00335.
   PubMed    
   
   
   
8. BODEN WE, Kaski JC, Al-Lamee R, Weintraub WS, et al
   What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?
   Lancet. 2022;399:691-694.
   PubMed    
   
   
   November 2021
9. BELLEY-COTE EP, Devereaux PJ
   PCI versus CABG for left main coronary artery disease: is the jury still out?
   Lancet. 2021 Nov 12. pii: S0140-6736(21)02491.
   PubMed    
   
   
   
10. VAN BOVEN WJ, de Groot JR, Kluin J
    A short cut to prevent postoperative atrial fibrillation.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02435.
    PubMed    
    
    
    
11. MEHRAN R, Owen R, Chiarito M, Baber U, et al
    A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02326.
    PubMed     Abstract available
    
    
    
12. SABATINE MS, Bergmark BA, Murphy SA, O'Gara PT, et al
    Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02334.
    PubMed     Abstract available
    
    
    
13. JOVIN TG, Nogueira RG, Lansberg MG, Demchuk AM, et al
    Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)01341.
    PubMed     Abstract available
    
    
    
14. DIPPEL D, Roozenbeek B
    Late thrombectomy for ischaemic stroke.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02097.
    PubMed    
    
    
    
15. KANG J, Koo BK, Park KW, Shin ES, et al
    Aspirin versus clopidogrel after percutaneous coronary intervention - Authors' reply.
    Lancet. 2021;398:1685-1686.
    PubMed    
    
    
    
16. PAREEK M, Byrne C
    Aspirin versus clopidogrel after percutaneous coronary intervention.
    Lancet. 2021;398:1685.
    PubMed    
    
    
    
17. XU B, Tu S, Song L, Jin Z, et al
    Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02248.
    PubMed     Abstract available
    
    
    October 2021
18. KIM CJ, Park MW, Kim MC, Choo EH, et al
    Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised tr
    Lancet. 2021;398:1305-1316.
    PubMed     Abstract available
    
    
    September 2021
19. TULAMO R, Venermo M
    Intervention for asymptomatic carotid artery stenosis.
    Lancet. 2021;398:1025-1027.
    PubMed    
    
    
    August 2021
20. HALLIDAY A, Bulbulia R, Bonati LH, Chester J, et al
    Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy.
    Lancet. 2021 Aug 27. pii: S0140-6736(21)01910.
    PubMed     Abstract available
    
    
    July 2021
21. MOSS JG, Wu O, Bodenham AR, Agarwal R, et al
    Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial.
    Lancet. 2021;398:403-415.
    PubMed     Abstract available
    
    
    
22. TAXBRO K, Chopra V
    Appropriate vascular access for patients with cancer.
    Lancet. 2021;398:367-368.
    PubMed    
    
    
    May 2021
23. KOO BK, Kang J, Park KW, Rhee TM, et al
    Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial.
    Lancet. 2021 May 14. pii: S0140-6736(21)01063.
    PubMed     Abstract available
    
    
    
24. AZIZI M, Sanghvi K, Saxena M, Gosse P, et al
    Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.
    Lancet. 2021 May 14. pii: S0140-6736(21)00788.
    PubMed     Abstract available
    
    
    April 2021
25. GALLI M, Benenati S, Capodanno D, Franchi F, et al
    Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Lancet. 2021;397:1470-1483.
    PubMed     Abstract available
    
    
    
26. SIBBING D, Kastrati A
    Guided P2Y12 inhibitor therapy after percutaneous coronary intervention.
    Lancet. 2021;397:1423-1425.
    PubMed    
    
    
    
27. RICKARD CM, Marsh NM, Larsen EN, McGrail MR, et al
    Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)-non-inferiority (peripheral arterial catheter) trial.
    Lancet. 2021;397:1447-1458.
    PubMed     Abstract available
    
    
    March 2021
28. LONNEBAKKEN MT
    The risk of no risk in STEMI.
    Lancet. 2021;397:1039-1040.
    PubMed    
    
    
    
29. FIGTREE GA, Vernon ST, Hadziosmanovic N, Sundstrom J, et al
    Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
    Lancet. 2021;397:1085-1094.
    PubMed     Abstract available
    
    
    November 2020
30. SILVAIN J, Lattuca B, Beygui F, Range G, et al
    Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial.
    Lancet. 2020 Nov 12. pii: S0140-6736(20)32236.
    PubMed     Abstract available
    
    
    October 2020
31. JEGER RV, Farah A, Ohlow MA, Mangner N, et al
    Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32173.
    PubMed     Abstract available
    
    
    
32. TAKAHASHI K, Serruys PW, Fuster V, Farkouh ME, et al
    Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNT
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32114.
    PubMed     Abstract available
    
    
    August 2020
33. FERRARI R, Ford I, Fox K, Challeton JP, et al
    Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020 Aug 28. pii: S0140-6736(20)31790.
    PubMed     Abstract available
    
    
    
34. KIM HS, Kang J, Hwang D, Han JK, et al
    Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial.
    Lancet. 2020 Aug 28. pii: S0140-6736(20)31791.
    PubMed     Abstract available
    
    
    July 2020
35. CHI G, Marszalek J
    Differential effect of ticagrelor on irreversible harms in diabetes.
    Lancet. 2020;396:93.
    PubMed    
    
    
    
36. CAMPBELL BCV, Khatri P
    Stroke.
    Lancet. 2020;396:129-142.
    PubMed     Abstract available
    
    
    April 2020
37. THE LANCET
    Open versus endovascular repair of aortic aneurysms.
    Lancet. 2020;395:1090.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: